PREVIOUS
✖
RISUG clinical trials
October 25 , 2023
398 days
707
0
- India has successfully completed the clinical trials for the world's first injectable long-Term male contraceptive.
- The trials of 60 mg of the innovative Reversible Inhibition of Sperm under Guidance (RISUG) are conducted by the ICMR.
- RISUG presents the highest effectiveness compared to all other contraceptives both male and female.
Leave a Reply
Your Comment is awaiting moderation.